AmpC β-lactamases and bacterial resistance: An updated mini review

Reviews and Research in Medical Microbiology

Volumn 20, Issue 3, 2009, Pages 41-55

  Shahid, Mohammad ^a   Sobia, Farrukh ^a   Singh, Anuradha ^a   Khan, Haris M ^a   Hawkey, Peter M ^b,c   Huq, Anwar ^d   Khardori, Nancy ^e  

^a ALIGARH MUSLIM UNIVERSITY   (India)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^d Bldg 142   (United States)

^e SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AmpC lactamases; Antibiotic resistance; Mini review

Indexed keywords

AMINOPENICILLIN; AMOXICILLIN; AMPICILLIN; BETA LACTAMASE AMPC; BETA LACTAMASE INHIBITOR; CARBAPENEM; CARBENICILLIN; CEFOTAXIME; CEFOTETAN; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN; CEPHAMYCIN; CLAVULANIC ACID; HEPATOCYTE NUCLEAR FACTOR 3ALPHA; HEPATOCYTE NUCLEAR FACTOR 3BETA; HEPATOCYTE NUCLEAR FACTOR 3GAMMA; LATAMOXEF; MONOBACTAM; OUTER MEMBRANE PROTEIN; PENICILLIN DERIVATIVE; PIPERACILLIN; RO 481220; SULBACTAM; SYN 2190; TAZOBACTAM; TICARCILLIN; UNCLASSIFIED DRUG; UREIDOPENICILLIN;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; BACTERIAL CHROMOSOME; BACTERIAL GENE; BACTERIAL STRAIN; CITROBACTER FREUNDII; DNA SEQUENCE; DRUG SENSITIVITY; ENTEROBACTER CLOACAE; ESCHERICHIA COLI; GENE CASSETTE; GENE EXPRESSION; GENE MUTATION; GENE REPLICATION; GENE SEQUENCE; GENETIC CODE; GENETIC VARIABILITY; HYDROLYSIS; ISOELECTRIC POINT; KLEBSIELLA PNEUMONIAE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; REPLICON; SALMONELLA; SERRATIA MARCESCENS; SHORT SURVEY; UNINDEXED SEQUENCE;

EID: 70349739710     PISSN: 0954139X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MRM.0b013e328331ad83     Document Type: Short Survey

References (124)

1. Sykes RB, Bush K. Physiology, biochemistry and inactivation of β-lactamases. In: Morin RB, Gorman M, editors. The chemistry and biology of beta-lactam antibiotics. New York: Academic Press; 1982. pp. 155-208.
2. Shahid M, Sobia F, Singh A, Malik A, Khan HM, Jonas D, Hawkey PM. Beta-lactams and beta-lactamase-inhibitors in current or potential clinical practice: a comprehensive update. Crit Rev Microbiol 2009; 35:81-108.
3. Bradford PA, Urban C, Mariano N, Projan SJ, Rahal JJ, Bush K. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC β-lactamase, and the loss of an outer membrane protein. Antimicrob Agents Chemother 1997; 41:563-569. (Pubitemid 27098404)
4. Bauernfeind A, Chong Y, Lee K. Plasmid-encoded AmpC β-lactamases: how far have we gone 10 years after the discovery. Yonsei Med J 1998; 39:520-525. (Pubitemid 29135017)
5. Ensor VM, Shahid M, Evans JT, Hawkey PM. Occurrence, prevalence and genetic environment of CTX-M β-lactamases in Enterobacteriaceae from Indian Hospitals. J Antimicrob Chemother 2006; 58:1260-1263. (Pubitemid 44884149)
6. Shahid M, Ensor VM, Hawkey PM. Emergence and dissemination of Enterobacteriaceae with plasmid-mediated CMY-6 and CTX-M-15 beta-lactamases in community in North-India. World J Microbiol Biotechnol 2009; 25:1439-1446.
7. Alvarez M, Tran JH, Chow N, Jacoby GA. Epidemiology of conjugative plasmid-mediated AmpC β-lactamases in the United States. Antimicrob Agents Chemother 2004; 48:533-537. (Pubitemid 38141713)
8. Sanders CC. β-Lactamases of gram-negative bacteria: new challenges for new drugs. Clin Infect Dis 1992; 14:1089-1099.
9. Philippon A, Labia R, Jacoby G. Extended-spectrum β-lactamases. Antimicrob Agents Chemother 1989; 33:1131-1136.
10. Jacoby GA, Medeiros AA. More extended-spectrum β-lactamases. Antimicrob Agents Chemother 1991; 35:1697-1704.
11. Jacoby GA. Genetics of extended-spectrum β-lactamases. Eur J Clin Microbiol Infect Dis 1994; 13:2-11.
12. Livermore DM. β-Lactamases in laboratory and clinical resistance. Clin Microbiol Rev 1995; 8:557-584.
13. Medeiros A. Evolution and dissemination of β-lactamases accelerated by generations of b-lactam antibiotics. Clin Infect Dis 1997; 24:S19-S45. (Pubitemid 27024343)
14. Stapleton PD, Shanon KP, French GL. Carbapenem resistance in Escherichia coli associated with plasmid-determined CMY- 4 β-lactamase production and loss of an outer membrane protein. Antimicrob Agents Chemother 1999; 43:1206-1210.
15. Cao VT, Arlet G, Ericsson BM, Tammelin A, Courvalin P, Lambert T. Emergence of imipenem resistance in Klebsiella pneumoniae owing to combination of plasmid-mediated CMY-4 and permeability alteration. J Antimicrob Chemother 2000; 46:895-900. (Pubitemid 32000598)
16. Maurelli AT, Fernández RE, Bloch CA, Rode CK, Fasano A. Black holes and bacterial pathogenicity: a large genomic deletion that enhances the virulence of Shigella spp. and enteroinvasive Escherichia coli. Proc Natl Acad Sci U S A 1998; 95:3943-3948. (Pubitemid 28173233)
17. Sanderson KE, Hessel A, Rudd KE. Genetic map of Salmonella typhimurium, edition VIII. Microbiol Rev 1995; 59:241-303.
18. Morosini MI, Ayala JA, Baquero F, Martínez JL, Blázquez J. Biological cost of AmpC production for Salmonella enterica serotype Typhimurium. Antimicrob Agents Chemother 2000; 44:3137-3143. (Pubitemid 30803080)
19. Bobrowski MM, Matthew M, Barth PT, Datta N, Grinter NJ, Jacob AE, et al. Plasmid-determined β-lactamase indistinguishable from the chromosomal β-lactamase of Escherichia coli. J Bacteriol 1976; 125:149-157.
20. Levesque R, Roy PH, Letarte R, Pechère JC. A plasmidmediated cephalosporinase from Achromobacter species. J Infect Dis 1982; 145:753-761.
21. Knothe H, Shah P, Krcmery V, Antal M, Mitsuhashi S. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection 1983; 11:315-317. (Pubitemid 14213754)
22. Bauernfeind A, Chong Y, Schweighart S. Extended broad spectrum β-lactamase in Klebsiella pneumoniae including resistance to cephamycins. Infection 1989; 17:316-321. (Pubitemid 19254313)
23. Papanicolaou GA, Medeiros AA, Jacoby GA. Novel plasmidmediated β-lactamase (MIR-1) conferring resistance to oxyimino- and α-methoxy b-lactams in clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother 1990; 34:2200-2209.
24. Payne DJ, Woodford N, Amyes SGB. Characterization of the plasmid mediated β-lactamase BIL-1. J Antimicrob Chemother 1992; 30:119-127.
25. Philippon A, Arlet G, Jacoby GA. Plasmid-determined AmpC type β-lactamases. Antimicrob Agents Chemother 2002; 46:1-11.
26. BouG,Oliver A,OjedaM,Monzon C, Beltran J-M. Molecular characterization of FOX-4, a new AmpC-type plasmid-mediated β-lactamase from an Escherichia coli strain isolated in Spain. Antimicrob Agents Chemother 2000; 44:2549-2553.
27. Nakano R, Okamoto R, Nakano Y, Kaneko K, Okitsu N, Hosaka Y, Inoue M. CFE-1, a novel plasmid encoded AmpC β-lactamasewith an ampR gene originating from Citrobacter freundii. Antimicrob Agents Chemother 2004; 48:1151-1158. (Pubitemid 38405468)
28. Doi Y, Shibata N, Shibayama K, Kamachi K, Kurokawa H, Yokoyama K, et al. Characterization of a novel plasmid-mediated cephalosporinase (CMY-9) and its genetic environment in an E. coli clinical isolate. Antimicrob Agents Chemother 2002; 46:2427-2434. (Pubitemid 34793445)
29. Hujer KM, Hamza NS, Hujer AM, Perez F, Helfand MS, Bethel CR, et al. Identification of a new allelic variant of the Acinetobacter baumanii cephalosporinase, ADC-7 β-lactamase: defining a unique family of class C enzymes. Antimicrob Agents Chemother 2005; 49:2941-2948.
30. Wachino J, Kurokawa H, Suzuki S, Yamane K, Shibata N, Kimura K, et al. Horizontal transfer of blaCMY- bearing plasmids among clinical Escherichia coli and Klebsiella pneumoniae isolates and emergence of cefepime-hydrolyzing CMY- 19. Antimicrob Agents Chemother 2006; 50:534-541. (Pubitemid 43190963)
31. Barlow M, Hall BG. Origin and evolution of the AmpC β-lactamases of Citrobacter freundii. Antimicrob Agents Chemother 2002; 46:1190-1198. (Pubitemid 34415290)
32. Bret L, Chanal-Claris C, Sirot D, Chaibi EB, Labia R, Sirot J. Chromosomally encoded AmpC-type beta-lactamase in a clinical isolate of Proteus mirabilis. Antimicrob Agents Chemother 1998; 42:1110-1114. (Pubitemid 28227906)
33. Barnaud G, Arlet G, Verdet C, Gaillot O, Lagrane PH, Phillipon A. Salmonella enteritidis: AmpC plasmid mediated inducible β-lactamase (DHA-1) with an ampR gene from Morgenella morganii. Antimicrob Agents Chemother 1998; 42:2352-2358. (Pubitemid 28420377)
34. Poirel L, Guibert M, Girlich D, Nass T, Nordmann P. Cloning, sequence analysis, expression, and distribution of ampC-ampR from Morganella morganii clinical isolates. Antimicrob Agents Chemother 1999; 43:769-776. (Pubitemid 29165738)
35. Lindberg F, Normark S. Contribution of chromosomal beta-lactamases to beta-lactam resistance in enterobacteria. Rev Infect Dis 1986; 8 (Suppl 3):S292-S304.
36. Nelson EC, Elisha BG. Molecular basis of AmpC hyperproduction in clinical isolates of Escherichia coli. Antimicrob Agents Chemother 1999; 43:957-959. (Pubitemid 29165767)
37. Caroff N, Espaze E, Gautreau D, Richet H, Reynaud A. Analysis of the effects of -42 and -32 ampC promoter mutations in clinical isolates of Escherichia coli hyperproducing AmpC. J Antimicrob Chemother 2000; 45:783-788. (Pubitemid 30348947)
38. Odeh R, Kelkar S, Hujer AM, Bonomo RA, Schreckenberger PC, Quinn P. Broad resistance due to plasmid mediated AmpC β-lactamases in clinical isolates of Escherichia coli. Clin Infect Dis 2002; 35:140-145. (Pubitemid 34753898)
39. M'Zali FH, Heritage J, Gascoyne-Binzi DM, Denton M, Todd NJ, Hawkey PM. Transcontinental importation into the UK of Escherichia coli expressing a plasmid-mediated AmpC-type β-lactamase exposed during an outbreak of SHV-5 extendedspectrum β-lactamase in a Leeds hospital. J Antimicrob Chemother 1997; 40:823-831. (Pubitemid 28022147)
40. Koeck JL, Arlet G, Philippon A, Basmaciogullari S, Thein HV, Buisson Y, Cavello JD. A plasmid-mediated CMY-2 β-lactamase from an Algerian clinical isolate of Salmonella seftenberg. FEMS Microbiol Lett 1997; 152:255-260. (Pubitemid 27305827)
41. Girlich D, Karim A, Spicq C, Nordmann P. Plasmid-mediated cephalosporinase ACC-1 in clinical isolates of Proteus mirabilis and Escherichia coli. Eur J Clin Microbiol Infect Dis 2000; 19:893-895.
42. Nadjar D, Rouveau M, Verdet C, Donay J, Herrmann J, Lagrange PH, et al. Outbreak of Klebsiella pneumoniae prodicing transferable AmpC-type β-lactamase (ACC-1) originating from Hafnia alvei. FEMS Microbiol Lett 2000; 187:35-40. (Pubitemid 30316452)
43. Yan JJ, Ko W-C,WuHM, Tsai SH, Chuang CL,WuJJ. Complexity of Klebsiella pneumoniae isolates resistant to both cephamycins and extended-spectrum cephalosporins at a teaching hospital in Taiwan. J Clin Microbiol 2004; 42:5337-5340.
44. Huang F, Chiu C, Wang M, Wu C, Hsieh K, Chiou CC. Outbreak of dysentery associated with Shigella sonnei: first report of plasmid-mediated CMY-2-type AmpC β-lactamase resistance in Shigella sonnei. J Clin Microbiol 2005; 43:2608-2612. (Pubitemid 40827928)
45. Fortineau N, Poirel L, Nordmann P. Plasmid-mediated and inducible cephalosporinase DHA-2 from Klebsiella pneumoniae. J Antimicrob Chemother 2001; 47:207-210. (Pubitemid 32149530)
46. Moland ES, Black JA, Ourada J, Reisbig MD, Hanson ND, Thomson KS. Occurrence of newer β-lactamases in Klebsiella pneumoniae isolates from 24 US hospitals. Antimicrob Agents Chemother 2002; 46:3837-3842. (Pubitemid 35403258)
47. Yan JJ, Ko W-C, Jung Y-C, Chuang C-L, Wu JJ. Emergence of Klebsiella pneumoniae isolates producing inducible DHA-1 β-lactamase in a university hospital in Taiwan. J Clin Microbiol 2002; 40:3121-3126.
48. Kim JY, Park YJ, Lee SO, Song W, Jeong SH, Yoo YA, Lee KY. Case report: bacteremia due to Salmonella enterica serotype Montevideo producing plasmid-mediated AmpC beta-lactamase (DHA-1). Ann Clin Lab Sci 2004; 34:214-217. (Pubitemid 38685918)
49. Liebana E, Batchelor M, Clifton-Hadley FA, Davies RH, Hopkins KL, Threlfall EJ. First report of Salmonella isolates with the DHA-1 AmpC β-lactamase in the United Kingdom. Antimicrob Agents Chemother 2004; 43:4492. (Pubitemid 39434928)
50. Gazouli M, Tzouvelekis LS, Prinarakis E, Miriagou V, Tzelepi E. Trasferable cefoxitin resistance in enterobacteria from Greek hospitals and characterization of a plasmid-mediated group 1 β-lactamase (LAT-2). Antimicrob Agents Chemother 1996; 40:1736-1740. (Pubitemid 26227370)
51. Kuga A, Okamoto R, Inoue M. ampR gene mutations that greatly increase class C β-lactamase activity in Enterobacter cloacae. Antimicrob Agents Chemother 2000; 44:561-567. (Pubitemid 30117941)
52. Bush K, Jacoby GA, Medieros AA. A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother 1995; 39:1211-1233.
53. Lee SH, Kim JY, Shin SH, An YJ, Choi YW, Jung YC, et al. Dissemination of SHV-12 and characterization of new AmpC-type beta-lactamase genes among clinical isolates of Enterobacter species in Korea. J Clin Microbiol 2003; 41:2477-2482.
54. Verdet C, Arlet G, Barnaud G, Lagrange PH, Phillipon A. A novel integron in Salmonella enterica serovar Enteridis, carrying the bla(DHA-1) gene and its regulator gene ampR, originated from Morganella morganii. Antimicrob Agents Chemother 2000; 44:222-225. (Pubitemid 30010705)
55. Hall RM, Collis CM. Antibiotic resistance in Gram-negative bacteria: the role of gene cassettes and integrons. Drug Resist Updates 1998; 1:109-119.
56. Stokes HW, Tomaras C, Parsons Y, Hall RM. The partial 3′- conserved segment duplications in the integrons In6 from pSa and In7 from pDGO100 have a common origin. Plasmid 1993; 30:2233-2239. (Pubitemid 23226132)
57. Valentine CR, Heinrich MJ, Chissoe SL, Roe BA. DNA sequence of direct repeats of the SulI gene of plasmid pSa. Plasmid 1994; 32:222-227.
58. Partridge SR, Hall RM. In34, a complex In5 family class 1 integron containing orf513 and dfrA10. Antimicrob Agents Chemother 2003; 47:342-349.
59. Verdet C, Benzerara Y, Gautier V, Adam O, Ould-Hocine Z, Arlet G. Emergence of DHA-1 producing Klebsiella spp. in the Parisian region: genetic organization of the ampC and ampR genes originating from Morganella morganii. Antimicrob Agents Chemother 2006; 50:607-617. (Pubitemid 43190973)
60. Barnaud G, Arlet G, Danglot C, Phillipon A. Cloning and sequencing of the gene encoding the AmpC β-lactamase of Morganella morganii. FEMS Microbiol Lett 1997; 148: 15-20. (Pubitemid 27128350)
61. Naas T, Mikami Y, Imami T, Poirel L, Nordman P. Characterization of In53, a class1 plasmid- and composite transposon-located integron of Escherichia coli which carries an unusual array of gene cassettes. J Bactriol 2001; 183:235-249. (Pubitemid 32003129)
62. Horii T, Arakawa Y, Ohta M, Sugiyama T, Wacharotayankun R, Ito H, Kato N. Characterization of plasmid-borne and costitutively expressed blaMOX-1 gene encoding AmpC type β-lactamase. Gene 1994; 139:93-98. (Pubitemid 24086745)
63. Wu SW, Dornbusch K, Kronvall G, Norgren M. Characterization and nucleotide sequence of a Klebsiella oxytoca cryptic plasmid encoding a CMY-type β-lactamase: confirmation that the plasmid-mediated cephamycinase originated from the Citrobacter freundii AmpC β-lactamase. Antimicrob Agents Chemother 1999; 43:1350-1357. (Pubitemid 29259324)
64. Tzouvelekis LS, Tzelepi E, Mentis AF, Tsakris A. Identification of a novel plasmid-mediated β-lactamase with chromosomal cephalosporinase characteristics from Klebsiella pneumoniae. J Antimicrob Chemother 1993; 31:645-654. (Pubitemid 23193725)
65. Gazouli M, Tzouvelekis LS, Vatopoulos AC, Tzelepi E. Transferable class C β-lactamase in Escherichia coli isolated in Greek hospitals and characterization of two enzyme variants (LAT-3 and LAT-4) closely related to Citrobacter freundii AmpC β-lactamase. J Antimicrob Chemother 1998; 42:419-425. (Pubitemid 28473000)
66. CMY-1 gene and its relationship with other β-lactamase genes. Antimicrob Agents Chemother 1996; 40:1926-1930.
67. Bauernfeind A, Wanger S, Jungwirth R, Schneider I, Meyer D. A novel class C β-lactamase (FOX-2) in Escherichia coli conferring resistance to cephamycins. Antimicrob Agents Chemother 1997; 41:2041-2046. (Pubitemid 27383256)
68. Martinez-Martinez L, Pascual A, Jacoby GA. Quinolone resistance from a transferable plasmid. Lancet 1998; 351:797-799.
69. BIL-1, a plasmid-mediated class C β-lactamase in Escherichia coli BS. Antimicrob Agents Chemother 1994; 38:1182-1185.
70. Jacoby GA, Tran J. Sequence of the MIR-1 β-lactamases. Antimicrob Agents Chemother 1999; 43:1759-1760.
71. Bishop RE, Penfold SS, Frost LS, Holtje JV, Weiner JH. Stationary phase expression of a novel Escherichia coli outer membrane lipoprotein and its relationship with mammalian apolipoprotien D. Implications for the origin of lipocalins. J Biol Chem 1995; 270:23097-23103.
72. Oefner C, D'Arcy A, Daly JJ, Gubernator K, Charnas RL, Heinze I, et al. Refined crystal structure of β-lactamase from Citrobacter freundii indicates a mechanism for β-lactam hydrolysis. Nature 1990; 343:284-288. (Pubitemid 20030649)
73. Jacoby GA. AmpC β-lactamases. Clin Microbiol Rev 2009; 22:161-182.
74. Rice LB. Successful intervention for Gram-negative resistance to extended-spectrum beta-lactamase antibiotics. Pharmacotherapy 1999; 19:120S-128S.
75. Martinez-Martinez L, Conejo MC, Pascual A, Harnandez- Alles S, Ballesta S, Ramirez De Arellano-Ramos E, et al. Activities of imipenem and cephalosporins against clonally related strains of Escherichia coli hyperproducing chromosomal β-lactamase and showing altered porin profiles. Antimicrob Agents Chemother 2000; 44:2534-2536. (Pubitemid 30650909)
76. Pai H, Kang CI, Byeon JH, Lee KD, Park WB, Kim HB, et al. Epidemiology and clinical features of bloodstream infections caused by AmpC-type beta-lactamase-producing Klebsiella pneumoniae. Antimicrob Agents Chemother 2004; 48:3720-3728. (Pubitemid 39304595)
77. Jacobs C, Frere J-M, Normark S. Cytosolic intermediates for cell wall biosynthesis and degradation control inducible β-lactam resistance in Gram-negative bacteria. Cell 1997; 88:823-832. (Pubitemid 27164270)
78. Normark S. β-Lactamase induction in Gram-negative bacteria is intimately linked to peptidoglycan recycling. Microb Drug Resist 1995; 1:111-114.
79. Lindberg F, Westman L, Normark S. Regulatory components in Citrobacter freundii ampC β-lactamase induction. Proc Natl Acad Sci U S A 1985; 82:4620-4624. (Pubitemid 16239615)
80. Bartowsky E, Normark S. Purification and mutant analysis of Citobacter freundii AmpR, the regulator of chromosomal AmpC β-lactamases. Mol Microbiol 1991; 5:1715-1725. (Pubitemid 21896202)
81. Bartowsky E, Normark S. Interaction of wild type and mutant ampR of Citrobacter freundii with target DNA. Mol Microbiol 1993; 10:555-565. (Pubitemid 23334436)
82. Bennett PM, Chopra I. Molecular basis of β-lactamase induction in bacteria. Antimicrob Agents Chemother 1993; 37:153-158. (Pubitemid 23046546)
83. Reisbig MD, Hanson ND. The ACT-1 plasmid-encoded AmpC beta lactamase is inducible: detection in a complex betalactamase background. J Antimicrob Chemother 2002; 49: 557-560.
84. Jaurin B, Normark S. Insertion of IS2 creates a novel ampC promoter in Escherichia coli. Cell 1983; 32:809-816.
85. Aoyama T, Takanami M, Ohtsuka E, Taniyama Y, Marumoto R, Sato H, Ikehara M. Essential structure of E. coli promoter: effect of spacer length between the two consensus sequence on promoter function. Nucleic Acids Res 1983; 11:5855-5864.
86. Brun-Buisson C, Legrand P, Philippon A, Montravers F, Ansquer M, Duval J. Transferable enzymatic resistance to thirdgeneration cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae. Lancet 1987; 2:302-306. (Pubitemid 17104206)
87. Jarlier V, Nicolas MH, Fournier G, Philippon A. Extended broad-spectrum β-lactamases conferring transferable resistance to newer b-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis 1988; 10:867-878.
88. Thomson KS, Mejglo ZA, Pearce GN, Regan TJ. 3-Dimensional susceptibility testing of beta-lactam antibiotics. J Antimicrob Chemother 1984; 13:45-54. (Pubitemid 14218673)
89. Vercauteren E, Descheemaeker P, Ieven M, Sanders CC, Goossens H. Comparison of screening methods for detection of extended-spectrum beta-lactamases and their prevalence among blood isolates of Escherichia coli and Klebsiella spp. in a Belgian teaching hospital. J Clin Microbiol 1997; 35:2191-2197. (Pubitemid 27349780)
90. Coudron PE, Moland ES, Thomson KS. Occurrence and detection of AmpC β-lactamases among Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis isolates at a Veterans Medical Centre. J Clin Microbiol 2000; 38:1791-1796.
91. Manchanda V, Singh NP. Occurrence and detection of AmpC β-lactamases among gram-negative clinical isolates using a modified three-dimensional test at Guru Tegh Bahadur Hospital, Delhi, India. J Antimicrob Chemother 2003; 51:415-418. (Pubitemid 36231167)
92. Shahid M, Malik A, Agrawal M, Singhal S. Phenotypic detection of the extended-spectrum and AmpC β-lactamases by a new spot inoculation method and modified three-dimensional extract test: comparison with conventional threedimensional extract test. J Antimicrob Chemother 2004; 54:684-687. (Pubitemid 39263912)
93. Black JA, Moland ES, Thomson KS. AmpC disk test for detection of plasmid-mediated AmpC β-lactamases in Enterobacteriaceae lacking chromosomal AmpC β-lactamases. J Clin Microbiol 2005; 43:3110-3113.
94. Black JA, Thomson KS, Buynak JD, Pitout JDD. Evaluation of β-lactamase inhibitors in disk tests for detection of plasmid-mediated AmpC β-lactamases in well characterized clinical strains of Klebsiella spp. J Clin Microbiol 2005; 43:4168-4171.
95. Babiani GS, Danel F, Munro SD, Micklesen PA, Livermore DM. Unusual tazobactam-sensitive AmpC β-lactamase from two Escherichia coli isolates. J Antimicrob Chemother 1998; 41:115-118. (Pubitemid 28064259)
96. Jacoby GA, Walsh KE, Walker VJ. Identification of extended-spectrum, AmpC, and carbapenem-hydrolyzing β-lactamases in Escherichia coli and Klebsiella pneumoniae by disk tests. J Clin Microbiol 2006; 44:1971-1976. (Pubitemid 43902141)
97. Yagi T, Wachino J, Kurokawa H, Suzuki S, Yamane K, Doi Y, et al. Practical methods using boronic acid compounds for identification of class C β-lactamase-producing Klebsiella pneumoniae and Escherichia coli. J Clin Microbiol 2005; 43:2551-2558. (Pubitemid 40827918)
98. Hernandez-Alles S, Conejo MC, Pascual A, Tomas JM, Benedi VJ, Martinez-Martinez L. Relationship between outer membrane alterations and susceptibility to antimicrobial agents in isogenic strains of Klebsiella pneumoniae. J Antimicrob Chemother 2000; 46:273-277. (Pubitemid 30639298)
99. Song W, Bae IK, Lee YN, Lee CH, Lee SH, Jeong SH. Detection of extended spectrum β-lactamases by using boronic acid as an AmpC β-lactamase inhibitor in clinical isolates of Klebsiella spp. and Escherichia coli. J Clin Microbiol 2007; 45:1180-1184. (Pubitemid 46626482)
100. Ruppe E, Bidet P, Verdet C, Arlet G, Bingen E. First detection of an AmpC β-lactamase in Citrobacter freundii by a new, simple double-disc synergy test. J Clin Microbiol 2006; 44:4204-4207. (Pubitemid 44737272)
101. Apfalter P, Assadian O, Daxbock F, Hirschl AM, Rotter ML, Makristathis A. Extended double disc synergy testing reveals a low prevalence of extended-spectrum β-lactamases in Enterobacter spp. in Vienna, Austria. J Antimicrob Chemother 2007; 59:854-859. (Pubitemid 47073355)
102. Cantarelli VV, Inamine E, Brodt TCZ, Secchi C, Cavalcante BC, Periera FS. Utility of ceftazidime-imipenem antagonism test (CIAT) to detect and confirm the presence of inducible AmpC β-lactamases among Enterobacteriaceae. Braz J Infect Dis 2007; 11:237-239. (Pubitemid 47099088)
103. Perez-Perez FJ, Hanson ND. Detection of plasmidmediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 2002; 40:2153-2162.
104. Zhu L, Zhang Z, Liang D, Jiang D, Wang C, Du N, et al. Multiplex asymmetric PCR-based oligonucleotide microarray for detection of drug resistance genes containing single mutations in Enterobacteriaceae. Antimicrob Agents Chemother 2007; 51:3707-3713. (Pubitemid 47519362)
105. Costas M, Holmes B, Sloss LL. Comparison of SDS-PAGE protein patterns with other typing methods for investigating the epidemiology of Klebsiella aerogenes. Epidemiol Infect 1990; 104:455-465. (Pubitemid 20345947)
106. Manchanda V, Singh NP, Shamweel A, Eideh HK, Thukral KK. Molecular epidemiology of clinical isolates of AmpC producing Klebsiella pneumoniae. Ind J Med Microbiol 2005; 24:177-181.
107. Couturier M, Bex F, Bergquist PL, Mass WK. Identification and classification of bacterial plasmids. Microbiol Rev 1988; 52:375-395.
108. Carattoli A, Bertani A, Villa L, Falbo V, Hopkins KL, Threlfall EJ. Identification of plasmids by PCR-based replicon typing. J Microbiol Methods 2005; 63:219-228. (Pubitemid 41597366)
109. Hopkins KL, Liebana E, Villa L, Batchelor M, Threlfall EJ, Carattoli A. Replicon typing of plasmids carrying CTX-M or CMY β-lactamases circulating among Salmonella and Escherichia coli isolates. Antimicrob Agents Chemother 2006; 50:3203-3206. (Pubitemid 44396441)
110. Lee SH, Lee JH, Heo MJ, Bae IK, Jeong SH, Cha SS. Exact location of the region responsible for the extended substrate spectrum in class C β-lactamases. Antimicrob Agents Chemother 2007; 51:3778-3779.
111. Kim JY, Jung HI, An YJ, Lee JH, Kim SJ, Jeong SH, et al. Structural basis for the extended substrate spectrum of CMY-10, a plasmid-encoded class C β-lactamase. Mol Microbiol 2006; 60:907-916.
112. Doi Y, Wachino J, Ishiguro M, Kurokawa H, Yamane K, Shibata N, et al. Inhibitor-sensitive AmpC β-lactamase variant produced by an Escherichia coli clinical isolate resistant to oxyiminocephalosporins and cephamycins. Antimicrob Agents Chemother 2004; 48:2652-2658. (Pubitemid 38823438)
113. Barnaud G, Labia R, Raskine L, Sanson-Le Pors MJ, Philippon A, Arlet G. Extension of resistance to cefepime and cefpirome associated to a six amino acid deletion in the H-10 helix of the cephalosporinase of an Enterobacter cloacae clinical isolate. FEMS Microbiol Lett 2001; 195: 185-190. (Pubitemid 32155376)
114. Mammeri H, Poirel L, Bemer P, Drugeon H, Nordman P. Resistance of cefepime and cefpirome due to a four amino acid deletion in the chromosome-encoded AmpC β-lactamase of a Serratia marcescens clinical isolate. Antimicrob Agents Chemother 2004; 48:716-720. (Pubitemid 38280315)
115. Barnaud G, Benzerara Y, Gravisse J, Raskine L, Sanson-Le Pors MJ, Labia G, Arlet G. Selection during cefepime treatment of a new cephalosporinase variant with extended-spectrum resistance to cefepime in an E. aerogenes clinical isolate. Antimicrob Agents Chemother 2004; 48:1040-1042. (Pubitemid 38280365)
116. Lee SH, Jeong SH, Cha SS. Minimising antibiotic resistance. Lancet Infect Dis 2005; 5:668-670.
117. Caroff N, Espaze E, Berard I, Richet H, Reynaud A. Mutations in the ampC promoter of Escherichia coli isolates resistant to oxyiminocephalosporins without extendedspectrum β-lactamase production. FEMS Microbiol Lett 1999; 173:459-465. (Pubitemid 29146152)
118. Brinas L, Zarazaga M, Saenz Y, Ruiz-Laerra F, Torres C. β- Lactamases in ampicillin-resiostant Escherichia coli isolates from foods, humans, and healthy animals. Antimicrob Agents Chemother 2002; 46:3156-3163. (Pubitemid 35052620)
119. Corvec S, Caroff N, Espaze E, Marraillac J, Reynaud A. 11 mutation in the ampC promoter increasing resistance to β-lactams in a clinical Escherichia coli strain. Antimicrob Agents Chemother 2002; 46:3265-3267. (Pubitemid 35052638)
120. Siu LK, Lu P-L, Chen J-Y, Lin FM, Chang S-C. High level of expression AmpC β-lactamase due to insertion of nucleotides between -10 and -35 promoter sequences in Escherichia coli clinical isolates: cases not responsive to extended-spectrum cephalosporin treatment. Antimicrob Agents Chemother 2003; 47:2138-2144.
121. Hawley DK, McClure WR. Compilation and analysis of Escherichia coli promoter DNA sequences. Nucleic Acids Res 1983; 11:2237-2255.
122. Forward KR, Wiley BM, Low DE, McGeer A, Kapala MA, Kapala MM, Burrows LL. Molecular mechanisms of cefoxitin resistance in Escherichia coli from Toronto area hospitals. Diagn Microbiol Infect Dis 2001; 41:57-63. (Pubitemid 33001460)
123. Mulvey MR, Bryce E, Boyd DA, Agostini MO, Land AM, Simor AE, Paton S, the Canadian Hospital Epidemiology-committae and Canadian nosocomial Infection Surveillance Program, Health Canada. Molecular characterization of cefoxitinresistant Escherichia coli from Canadian hospitals. Antimicrob Agents Chemother 2005; 49:358-365.
124. Jurian B, Grundstorm T, Edlund T, Normark S. The E. coli β-lactamase attenuator mediates growth rate-dependent regulation. Nature 1981; 290:221-225. (Pubitemid 11149648)